Holoclara
CA - Los AngelesBiotechnology
Focus: Holoclara is a public biotech company developing orally-available therapies derived from worms, a novel platform approach to treatment discovery. The company operates from Los Angeles with a focus on inflammatory disease indications.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Holoclara
AI assessmentNot HiringNo open roles listed right now. Follow Holoclara to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
HC002 SAD
Inflammatory DiseaseClinical Trials (1)
NCT06670274A Dose Escalating Study of HC002 in Healthy Adult Volunteers
Phase 1Help build intelligence for Holoclara
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.